Verition Fund Management
ALXO icon

Verition Fund Management’s ALX Oncology ALXO Stock Holding History

Verition Fund Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-133,025
Closed -$242K – 3222
2024
Q3 		$242K Buy
133,025
+100,454
+308% +$373K ﹤0.01% 2767
2024
Q2 		$196K Buy
+32,571
New +$401K ﹤0.01% 2605
2023
Q4 		– Sell
-11,649
Closed -$55.9K – 2306
2023
Q3 		$55.9K Buy
+11,649
New +$63.2K ﹤0.01% 2178

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Verition Fund Management's ALXO Position: Q4 2024 in Review

Verition Fund Management sold out of ALX Oncology (ALXO) in Q4 2024, closing a stake of 133,025 shares — an estimated $242K sold.

Verition Fund Management first reported a position in ALXO in Q3 2023 and held it in 3 quarters. The position peaked at $242K in Q3 2024. 87 funds tracked by Wall St. Rank hold ALXO as of Q4 2024.

  • Verition Fund Management reported no remaining ALX Oncology position as of Q4 2024 after selling out during the quarter.
  • Verition Fund Management sold 133,025 ALX Oncology shares in Q4 2024, an estimated $242K.
  • Verition Fund Management first reported a position in ALX Oncology in Q3 2023 and held it in 3 quarters.
  • Verition Fund Management's ALX Oncology position peaked at $242K in Q3 2024.
  • 87 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.